The University of Texas MD Anderson Cancer Center and Myriad Genetics (MYGN) announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular ...
HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to ...
Morningstar brands and products Company Portfolio ...
HOUSTON and SALT LAKE CITY ― The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and ...